SLC13A4 and head and neck squamous cell carcinoma: Our study helps clarify the role of SLC13A4 in the prognosis of HNSCC patients and the transformation from metabolic dominance to immune one in TME, and pave the way to future application of the biomarker in the diagnosis and prognostic prediction of HNSCC [28].